After careful consideration of the public interest consequences of ASC 605-15-S99-1,would it be appropriate for the SEC to modify its revenue recognition position exclusively for pharmaceutical companies stockpiling vaccines for the federal government by allowing them to recognize revenue on stockpiled vaccines? Why or why not?

Answer rating: 100% (QA)

Why is it appropriate for the SEC to change its position of financial recognition only in pharmaceut... View the full answer